title: Increased IP-10 and MIG expression after intra-amniotic endotoxin in preterm lamb lung.
abstract: Subtraction hybridization was performed to explore changes in gene expression in the fetal lung after 20 mg of intra-amniotic (IA) endotoxin. Interferon-gamma-inducible 10-kd protein (IP-10) and monokine induced by interferon-gamma (MIG) constituted 20% of 102 endotoxin-induced clones identified in the preterm lamb lung. IP-10 (CXCL10) and MIG (CXCL9) are T-cell chemoattractants that have angiostatic properties. Both IP-10 and MIG mRNA were induced 30- to 40-fold in the fetal lung at 1 to 2 days after IA endotoxin. Intense IP-10 mRNA expression was detected by in situ hybridization in the bronchiolar and peribronchiolar areas and the vascular endothelium after IA endotoxin at all time points tested. MIG mRNA expression was detected initially focally in infiltrating neutrophils (15 hours after IA endotoxin) and later in the bronchiolar and peribronchiolar areas and vascular endothelium (1 day after IA endotoxin). In contrast to endotoxin, IA tumor necrosis factor-alpha or interleukin-1 alpha did not induce IP-10 or MIG mRNA in the lung. IA endotoxin also caused a modest induction of IP-10 and MIG mRNA in the jejunum, liver, and spleen. The IP-10 and MIG receptor CXCR3 was detected in the bronchiolar epithelium of preterm lambs by immunostaining. IP-10 and MIG are potent angiostatic chemokines that may contribute to lung injury and altered pulmonary vascular development in the preterm exposed to chorioamnionitis.
authors.affiliation: Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229-3039, USA. kalls0@chmcc.org
authors.forename: Suhas G
authors.initials: SG
authors.lastname: Kallapur
authors.forename: Alan H
authors.initials: AH
authors.lastname: Jobe
authors.forename: Machiko
authors.initials: M
authors.lastname: Ikegami
authors.forename: Cindy J
authors.initials: CJ
authors.lastname: Bachurski
mesh_terms: D000650:Amnion; D000818:Animals; D001997:Bronchopulmonary Dysplasia; D054357:Chemokine CXCL10; D054370:Chemokine CXCL9; D019743:Chemokines, CXC / Q000235:genetics / Q000502:physiology*; D002821:Chorioamnionitis; D003627:Data Interpretation, Statistical; D004195:Disease Models, Animal; D004730:Endothelium, Vascular / Q000378:metabolism; D004731:Endotoxins / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D017403:In Situ Hybridization; D007231:Infant, Newborn; D036341:Intercellular Signaling Peptides and Proteins; D007371:Interferon-gamma; D007375:Interleukin-1; D008168:Lung / Q000378:metabolism* / Q000473:pathology; D009504:Neutrophils / Q000378:metabolism; D011247:Pregnancy; D012333:RNA, Messenger / Q000032:analysis; D012756:Sheep; D018709:Statistics, Nonparametric; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha
chemical_list: C080810:CXCL9 protein, human; D054357:Chemokine CXCL10; D054370:Chemokine CXCL9; D019743:Chemokines, CXC; D004731:Endotoxins; D036341:Intercellular Signaling Peptides and Proteins; D007375:Interleukin-1; D012333:RNA, Messenger; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma